Recent findings challenge previous assumptions about the genesis of atherosclerosis.
A new study suggests that inpatient statin use is linked to improved outcomes after intracranial hemorrhage.
These agents lower cholesterol and prevent cardiovascular disease, but they may actually increase the risk of Parkinson disease. Caution advised.
Contrave, a combination of naltrexone and buproprion, has been approved for long-term weight loss management in overweight and obese adults.